DexCom, Inc.
77.94USD
-0.3800 (-0.49%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on DXCM.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.67▲ | $0.67 | 1 | 1 |
| Next quarter | $0.74▼ | $0.75 | 1 | 0 |
| Current year | $2.66▲ | $2.59 | 1 | 1 |
| Next year | $3.12▲ | $3.08 | 0 | 2 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.61 | $0.7 | +0.09 (+15.1%) |
| 2026-03-31 | $0.47 | $0.56 | +0.09 (+19.0%) |
| 2025-12-31 | $0.65 | $0.68 | +0.03 (+4.5%) |
| 2025-09-30 | $0.57 | $0.61 | +0.04 (+7.5%) |
360 ratings from 47 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $90 $96 | Oct 12, 2026 |
| Barclays | Initiated | Overweight | $115 | Oct 7, 2026 |
| RBC Capital | Maintained | Outperform | $90 $105 | Oct 1, 2026 |
| Truist Securities | Maintained | Buy | $93 $102 | Sep 18, 2026 |
| TD Cowen | Reiterated | Buy | $95 | Sep 18, 2026 |
| Argus Research | Maintained | Buy | $86 $96 | Aug 4, 2026 |
| Canaccord Genuity | Maintained | Buy | $82 $90 | Aug 3, 2026 |
| Citigroup | Maintained | Buy | $84 $88 | Jul 31, 2026 |
| RBC Capital | Maintained | Outperform | $85 $90 | Jul 31, 2026 |
| Mizuho | Maintained | Outperform | $90 $95 | Jul 31, 2026 |
| JP Morgan | Maintained | Neutral | $65 $82 | Jul 31, 2026 |
| Piper Sandler | Reiterated | Overweight | $88 $95 | Jul 31, 2026 |
| Wells Fargo | Maintained | Overweight | $85 $90 | Jul 31, 2026 |
| Stifel | Maintained | Buy | $90 $95 | Jul 31, 2026 |
| Benchmark | Maintained | Buy | $77 $82 | Jul 31, 2026 |
| Truist Securities | Maintained | Buy | $87 $93 | Jul 31, 2026 |
| BTIG | Maintained | Buy | $80 $90 | Jul 31, 2026 |
| Truist Securities | Maintained | Buy | $80 $87 | Jul 16, 2026 |
| Mizuho | Maintained | Outperform | $85 $90 | Jul 15, 2026 |
| Deutsche Bank | Initiated | Buy | $86 | Jun 23, 2026 |
| Piper Sandler | Maintained | Overweight | $75 $88 | Jun 15, 2026 |
| TD Cowen | Maintained | Buy | $75 $95 | Jun 10, 2026 |
| Mizuho | Maintained | Outperform | $75 $85 | Jun 9, 2026 |
| Stifel | Maintained | Buy | $85 $90 | Jun 5, 2026 |
| Citigroup | Maintained | Buy | $79 $84 | May 28, 2026 |
120 filings from 23 insiders · 16 buy / 19 sell over 6m
Officers and directors of DXCM, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Brown Michael JonOfficer, EVP Chief Legal Compliance Off | Sell | 1.7k | $85.48 | $145k | Oct 15, 2026 |
| Stern SadieOfficer, EVP Chief People & Culture Off | Sell | 2.6k | $86.15 | $221k | Sep 28, 2026 |
| AUGUSTINOS NICHOLASDirector | Sellindirect | 6.5k | $84.04 | $550k | Sep 15, 2026 |
| Brown Michael JonOfficer, EVP Chief Legal Compliance Off | Sell | 1.7k | $84.04 | $143k | Sep 15, 2026 |
| AUGUSTINOS NICHOLASDirector | Sellindirect | 1.6k | $84.02 | $130k | Sep 14, 2026 |
| Sylvain Jereme MOfficer, EVP, Chief Financal Officer | Sell | 3.6k | $83.27 | $303k | Sep 10, 2026 |
| Boehnlein Glenn SDirector | Grant | 5.8k | — | — | Sep 10, 2026 |
| STERN SADIEOfficer | Sell | 2.6k | $88.37 | $227k | Aug 27, 2026 |
| SAYER KEVIN ROfficer and Director | Sell | 26.8k | $89.71 | $2.41M | Aug 20, 2026 |
| BROWN MICHAEL JONOfficer | Sell | 1.7k | $91.93 | $156k | Aug 14, 2026 |
| AUGUSTINOS NICHOLASDirector | Giftindirect | 1.1k | — | — | Aug 12, 2026 |
| HELLER BRIDGETTE PDirector | Sell | 1.0k | $88.29 | $89k | Aug 12, 2026 |
| FOLETTA MARK GDirector | Sellindirect | 4.0k | $80.00 | $331k | Aug 3, 2026 |
| SAYER KEVIN ROfficer and Director | Sell | 26.8k | $76.32 | $2.04M | Jul 20, 2026 |
| BROWN MICHAEL JONOfficer | Sell | 1.7k | $74.42 | $127k | Jul 15, 2026 |
| SAYER KEVIN ROfficer and Director | Sell | 26.8k | $72.00 | $1.93M | Jul 6, 2026 |
| BROWN MICHAEL JONOfficer | Sell | 1.7k | $75.55 | $128k | Jun 15, 2026 |
| FOLETTA MARK GDirector | Sellindirect | 4.0k | $74.10 | $297k | Jun 15, 2026 |
| COLEMAN JONOfficer | Sell | 9.8k | $73.00 | $723k | Jun 4, 2026 |
| FOLETTA MARK GDirector | Grant | 6.3k | — | — | May 28, 2026 |
No analyst notes on DXCM yet.
Analyst Ratings
26 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 22 | 3 | 0 | 0 | Buy1.97 |
| 1 mo ago | 3 | 22 | 3 | 0 | 0 | Buy2.00 |
| 2 mo ago | 3 | 22 | 3 | 0 | 0 | Buy2.00 |
| 3 mo ago | 3 | 22 | 3 | 0 | 0 | Buy2.00 |
Members whose judged calls on DXCM have played out most reliably.
No settled calls on DXCM yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice